NEU1 and cardiomyopathy: In this study, we uncovered that NEU1 acted as a critical driver of DOX cardiotoxicity, and NEU1 inhibitor had potentials to effectively improve cardiac dysfunction in DOX-induced cardiomyopathy by suppressing Drp1-mediated mitochondrial fission and mitophagy (Figure 8).